American Pharma giant Johnson and Johnson seeks permission for phase 3 trial of its single-shot Covid-19 vaccine on Monday.
The company has sought grant of import license in India, reported PTI.
They said the company has sought an early meeting of the subject expert committee on Covid-19 of the Central Drugs Standard Control Organisation (CDSCO) to take a decision on its application.
J&J is the only manufacturer with single-shot vaccine against Covid-19, though the vaccine has been banned in certain countries due to blood clot rumours.
